Warning: file_put_contents(/srv/users/serverpilot/apps/bitupdateus/public/wp-content/plugins/bulk-post-0.4-1/cache/sessions//hmdlPsHjwiVDrVyOourqSpegwt1nqvjAaWPXI2HU): failed to open stream: No space left on device in /srv/users/serverpilot/apps/bitupdateus/public/wp-content/plugins/stupidpie-1.8.3-1/vendor/illuminate/filesystem/Filesystem.php on line 122
  GNW: GLOBAL BIOENERGIES: PUBLICATION OF THE HALF YEAR RESULTS AT 30.06.2017 News | Bit Updates
Home » bitcoin updates » GNW: GLOBAL BIOENERGIES: PUBLICATION OF THE HALF YEAR RESULTS AT 30.06.2017 News

GNW: GLOBAL BIOENERGIES: PUBLICATION OF THE HALF YEAR RESULTS AT 30.06.2017 News

Monday, October 2nd, 2017 | bitcoin updates

GLOBAL BIOENERGIES: PUBLICATION OF HALF YEARS RESULTS AT 30.06.2017GLOBAL BIOENERGIES: PUBLICATION OF HALF YEAR RESULTS AT 30.06.2017Not lost of 7.8Mio.Euro in the first half year 2017Netto cash position of 8.4Mio.Euro as of June 30, 2017, short before the capital increase of EUR 10.2 millionEvry, October 2, 2017 – Global Bioenergies (Euronext Growth Paris: ALGBE) publishes and approves the half-year financial statements as of June 30, 2017 audited and approved by the Board of Directors on September 29, 2017. The Business Performance Report The consolidated financial statements for the first half-year2017 as well as the consolidated financial statements for the period under review are available on Global Bioenergies' website under the heading "Investors / Notices." * Consolidated Statements of Income as at 30 June 2017 + ——– ————————————————– ——————– + | || || Figures in EUR thousand from 01.01.17 from 01.07.16 from 01.01.16 || || CONSOLIDATED until 30.06.17 until 31.12.16 to 30.06.16 || CONSOLIDATED FINANCIAL STATEMENTS || || 6 months 6 months 6 months || || | + ———————————————— —————————— + | || || Operating income 1,209 2,525 767 || || Operating expenses 8,655 8,016 7,200 || || Operating result -7,446 -5,491 -6,433 || || || || Financial results -368 -285 -245 || || Extraordinary results 15 -18 -32 || || || || Profit taxes n. Z. * -1.896 n. Z. * || || | + ———————————————— —————————— + | Net result -7.799 -3.898 -6.709 | + ——— ————————————————– ——————- + * Note: The Group does not recognize any research tax credits for the half-year financial statements at the end of June. The Group's operating expenses increased due to the acquisition of the Syngip in Syngip in February and the start of the Depreciation of the demonstration facility Leuna. These two items accounted for 460,000 and 700,000 euros, respectively, for the first half-year. Non-operating expenses remained stable compared to the previous half-year period. The operating income was mainly driven by the Ministry of Education and Research funding (6.1 million euro for the construction and operation of the Leuna demonstration facility in the period 2013-2017) and the European Commission for adaptation of the procedure to the use of second-generation sugar (4.4 million euro over 4 years) * Consolidated balance sheet as at 30 June 2017 + ——————— ———————– + + ————————- ——————- + | Assets in EUR thousand 30.06.17 31.12.16 || Liabilities in EUR thousand 30.06.17 31.12.16 | + — ———————– + ——– + ——– + + ——- ——————- + ——– + ——– + | | | || | | || | | | | | | Intangible fixed assets 1271 | 69 || Capital | 184 | 168 || | | | | | | || Property, plant and equipment 12069 | 12.182 || Emissionsagio | 55473 | 49409 || | | | | | | || Financial investments 365 | 146 || Profit and loss carryforward -40673 | -30,066 || | | | | | | || | | || Result | -7799 | -10,607 || | | | | | | || | | || Investments 638 | 391 || | | | | | | || | | || | | || | | | | | | || INVESTMENT 13705 | 12,397 || CAPITAL OF SHAREHOLDERS 7823 | 9295 || | | | | | | || | | || | | || | | | | | | || | | || RESERVATIONS | 51 | 42 || | | | | | | || | | || | | || | | | | | | || Finances – Receivables – | 3212 | 5.074 || Conditional advances and | 12,159 | 11,483 || Prepaid expenses | | | Loans | | || | | | | | | || Liquid Resources – | 9322 | 8,066 || Receivables from | 3384 | 4.120 || Securities holdings | | | | Supplies and services | || | | | | | | || | | || Other liabilities | || | | | | and | 2821 | 597 || | | | | Prepaid expenses | | || | | | | | | || | | || | | || | | | | | | || CIRCULATION | 12534 | 13.140 || LIABILITIES | 18365 | 16,200 || | | | | | | || || | + ————————– + ——– + ——– + + – ———————— + ——– + ——– + | TOTAL ACTIVITIES | 26239 | 25.537 || TOTAL PASSIVES | 26239 | 25.537 | + ————————– + ——– + ——– + + – ————————- + ——– + ——– + The completion of the demonstration facility Leuna and The acquisition of the Dutch start-up Syngip includes intangible assets of EUR 1.14 million, which is the difference between the acquisition value (EUR 875,000) and the value of the company's equity at the time of acquisition (-260,000 euros) Euro). On the 30th of June, The successful completion of the capital increase of EUR 10.24 million was booked in the second half of the year, as reflected in the investment certificate dated July 4, and therefore is not reflected in this balance sheet. * Presentation of the cash flow of the Global Bioenergies Group as of June 30, ————————————————– ————————— + | CASH FLOW in EUR thousand H1 2017 2016 2015 | + ———- ——————————————— || || || Cash flow from operating activities -3,736 -9,279 -8,840 || || Net result -7.799 -10.607 -10.395 || || Depreciation and amortization (+) 1,097 1,213 979 || || Profit on disposal of investment assets (-) – 138 – || || Impact of the fluctuations of 2,965 115 576 || Operating capital requirements || || || || Cash flow from investing activities -1,180 -6,120 -4,488 || || Cash flow from financing activities 5,906 12,676 7,873 || || | + ———————————————— —————————— + The cash flow overview illustrates the end of the large investment projects that have been made during the last years of investment in the And the Leuna Demonstration Plant LeunaThe construction of the Leuna industrial demonstration plant began in the first half of the year 2015 and was completed in November 2016. In the first half of the year, The production has been step-by-step, with each stage which has been successively tested and validated prior to the granting of the operating license for the production of isobutene. After the first encouraging results, the teams are continuing to improve their performance with the aim of progressively stepping up the targets. Developing industrial and trade agreementsGlobal Bioenergies has formed a European consortium with Clariant and Innovas, both leading European companies in the chemical industry. The four-year project aims to produce isobutene derivatives from wheat stalks. This consortium has received a European grant of € 9.8 million, including € 4.4 million for global bioenergies. Global Bioenergies has also partnered with the Butagaz Group to introduce bioisobuten batches in the butane and propane industries, of tests to validate the consistency of the isobutene produced by the process developed by Global Bioenergies. Acquisition of Syngip BVGlobal Bioenergies completed the acquisition of Syngip BV in February, a Dutch start-up focused on the conversion of third-generation raw materials (approx of gases emitted by steelworks) in fuels and materials. This work is still at an early stage of research and development and has the prospect of transforming pollutant waste gases into products which are important markets of interest.Capital growth through private placement (in the second half of the year) On June 29, Global Bioenergies launched a capital increase through private placement, which led to a successful issue of 640,000 new common shares at the beginning of July leading to an inflow of funds of EUR 10.24 million "Marc Delcourt, co-founder and CEO of Global Bioenergies, explains:" Through recent successes with our industrial demonstration facility, we can turn to the next chapter with serenity. The objectives are set out in a definite way, and we have the means to achieve it. "About GLOBAL BIOENERGIESGlob al Bioenergies is one of the few companies in the world and the only one in Europe to develop the fermentative process for the conversion of renewable raw materials into hydrocarbons. The company initially focuses on the organic production of isobutene, one of the most important petrochemical raw materials from which fuels, plastics, organic glass and elastomers can be produced. Global Bioenergies is currently improving the performance of this process, is launching tests in an industrial demonstration plant in Germany and is preparing the first large-scale production facility in an IBN-One joint venture with Cristal Union. Global Bioenergies is listed on the Parisian Brse Euronext Growth (FR0011052257 – ALGBE). If you would like to stay updated, subscribe to our news feed at www.global-bioenergies.comFollow us on Twitter: @GlobalBioenergiContact GLOBAL BIOENERGIESFranois-Henri ReynaudFinanzvorstandTel: +33 1 64 98 20 50Email: invest@global-bioenergies.comGLOBAL BIOENERGIES – PRESS RELEASE: http: //hugin.info/166909/R/2138728/818719.pdfThis announcement is distributed by Nasdaq Corporate Solutions The GLOBAL BIOENERGIES website is the world's largest online resource for the world's largest solar energy company.

Related

A Blockchain Phone: What

Last year, Sirin Labs launched the Finney Smartphone, the first mobile phone to

1. FC Union Berlin: Sebas

For almost a minute, Sebastian Polter was in the box. His drenched jersey

OTS: PTV Group / PTV AG s

Sale of PTV AG to Porsche SE completed (FOTO) Karlsruhe (ots) – The

Two heavyweights in the f

The European Central Bank and the Federal Reserve are determining the euro-dollar exchange